Role of the tachykinin NK1 receptor in a murine model of cigarette smoke-induced pulmonary inflammation

Respiratory Research

Volumn 10, Issue , 2009, Pages

  De Swert, Katelijne O ^a   Bracke, Ken R ^a   Demoor, Tine ^a   Brusselle, Guy G ^a   Joos, Guy F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; CIGARETTE SMOKE; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SUBSTANCE P; TACHYKININ NK1 RECEPTOR; TACHYKININ RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ISOINDOLE DERIVATIVE; NEUROKININ 1 RECEPTOR; TACHYKININ;

AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DENDRITIC CELL; EMPHYSEMA; ENZYME SYNTHESIS; FEMALE; HISTOPATHOLOGY; INFLAMMATORY CELL; KNOCKOUT GENE; LONG TERM EXPOSURE; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; WILD TYPE; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; INFLAMMATION; LUNG; LUNG DISEASE; LUNG LAVAGE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SMOKE; SMOKING;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EMPHYSEMA; FLOW CYTOMETRY; INFLAMMATION; ISOINDOLES; LUNG; LUNG DISEASES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, NEUROKININ-1; SMOKE; SMOKING; TACHYKININS;

EID: 70249107527     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-37     Document Type: Article

References (57)

1. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004, 364:613-620. 10.1016/S0140-6736(04)16855-4, 15313363.
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
3. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22:672-688. 10.1183/09031936.03.00040703, 14582923.
4. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:S29-S32.
5. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S, Hogg JC. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001, 164:469-473.
6. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995, 152:1666-1672.
7. Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993, 92:537-548. 10.1016/0091-6749(93)90078-T, 8409114.
8. Casolaro MA, Bernaudin JF, Saltini C, Ferrans VJ, Crystal RG. Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988, 137:406-411.
9. Soler P, Moreau A, Basset F, Hance AJ. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Am Rev Respir Dis 1989, 139:1112-1117.
10. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997, 155:852-857.
11. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
12. Joos GF, De Swert KO, Pauwels RA. Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur J Pharmacol 2001, 429:239-250. 10.1016/S0014-2999(01)01323-1, 11698044.
13. Maggi CA. The troubled story of tachykinins and neurokinins. Trends Pharmacol Sci 2000, 21:173-175. 10.1016/S0165-6147(00)01463-2, 10785650.
14. Myers AC, Goldie RG, Hay DW. A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial Ganglia neurons. Am J Respir Crit Care Med 2005, 171:212-216. 10.1164/rccm.200405-600OC, 15477495.
15. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, Shirato K. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995, 151:613-617.
16. Lee LY, Kou YR, Frazier DT, Beck ER, Pisarri TE, Coleridge HM, Coleridge JC. Stimulation of vagal pulmonary C-fibers by a single breath of cigarette smoke in dogs. J Appl Physiol 1989, 66:2032-2038. 10.1063/1.344342, 2568354.
17. Andre E, Campi B, Materazzi S, Trevisani M, Amadesi S, Massi D, Creminon C, Vaksman N, Nassini R, Civelli M, Baraldi PG, Poole DP, Bunnett NW, Geppetti P, Patacchini R. Cigarette smoke-induced neurogenic inflammation is mediated by alpha, beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest 2008, 118:2574-2582. 2430498, 18568077.
18. Bergren DR. Enhanced lung C-fiber responsiveness in sensitized adult guinea pigs exposed to chronic tobacco smoke. J Appl Physiol 2001, 91:1645-1654.
19. Bardelli C, Gunella G, Varsaldi F, Balbo P, Del BE, Bernardone IS, Amoruso A, Brunelleschi S. Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway. Br J Pharmacol 2005, 145:385-396. 1576149, 15778738, 10.1038/sj.bjp.0706198.
20. Kwong K, Wu ZX, Kashon ML, Krajnak KM, Wise PM, Lee LY. Chronic smoking enhances tachykinin synthesis and airway responsiveness in guinea pigs. Am J Respir Cell Mol Biol 2001, 25:299-305.
21. Barnes PJ. Neurogenic inflammation in the airways. Respir Physiol 2001, 125:145-154. 10.1016/S0034-5687(00)00210-3, 11240158.
22. Matsumoto K, Aizawa H, Inoue H, Shigyo M, Takata S, Hara N. Thromboxane causes airway hyperresponsiveness after cigarette smoke-induced neurogenic inflammation. J Appl Physiol 1996, 81:2358-2364.
23. D'hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005, 26:204-213. 10.1183/09031936.05.00095204, 16055867.
24. Bracke KR, D'hulst AI, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006, 177:4350-4359.
25. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F, Hunt SP. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998, 392:394-397. 10.1038/32904, 9537323.
26. Bracke KR, D'hulst AI, Maes T, Demedts IK, Moerloose KB, Kuziel WA, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice. Clin Exp Allergy 2007, 37:1467-1479.
27. Vermaelen K, Pauwels R. Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: Methodology and new insights. Cytometry 2004, 61A:170-177.
28. Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis 1967, 95:752-764.
29. Saetta M, Shiner RJ, Angus GE, Kim WD, Wang NS, King M, Ghezzo H, Cosio MG. Destructive index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis 1985, 131:764-769.
30. D'hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?. Respir Res 2005, 6:147. 1334210, 16359546, 10.1186/1465-9921-6-147.
31. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997, 277:2002-2004. 10.1126/science.277.5334.2002, 9302297.
32. Lohmann-Matthes ML, Steinmuller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994, 7:1678-1689.
33. Holt PG, Haining S, Nelson DJ, Sedgwick JD. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol 1994, 153:256-261.
34. Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997, 159:5654-5660.
35. Lambrecht BN, Germonpre PR, Everaert EG, Carro-Muino I, De VM, De FC, Hunt SP, Thielemans K, Joos GF, Pauwels RA. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 1999, 29:3815-3825. 10.1002/(SICI)1521-4141(199912)29:12<3815::AID-IMMU3815>3.0.CO;2-#, 10601989.
36. Wiedermann CJ, Wiedermann FJ, Apperl A, Kieselbach G, Konwalinka G, Braunsteiner H. In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P. Naunyn Schmiedebergs Arch Pharmacol 1989, 340:185-190. 10.1007/BF00168967, 2478893.
37. Ruff MR, Wahl SM, Pert CB. Substance P receptor-mediated chemotaxis of human monocytes. Peptides 1985, 6(Suppl 2):107-111. 10.1016/0196-9781(85)90142-1, 2417206.
38. Kradin R, MacLean J, Duckett S, Schneeberger EE, Waeber C, Pinto C. Pulmonary response to inhaled antigen: neuroimmune interactions promote the recruitment of dendritic cells to the lung and the cellular immune response to inhaled antigen. Am J Pathol 1997, 150:1735-1743. 1858203, 9137097.
39. Dunzendorfer S, Kaser A, Meierhofer C, Tilg H, Wiedermann CJ. Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol 2001, 166:2167-2172.
40. Dusser D. Inflammation neurogène radicaux libres et tabac. Rev Fr Allergol 1997, 37:851-858.
41. Caux C, Vanbervliet B, Massacrier C, Ait-Yahia S, Vaure C, Chemin K, Dieu-Nosjean And MC, Vicari A. Regulation of dendritic cell recruitment by chemokines. Transplantation 2002, 73:S7-11. 10.1097/00007890-200201151-00005, 11810053.
42. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, Lebecque S, Dezutter-Dambuyant C, Schmitt D, Zlotnik A, Caux C. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000, 192:705-718. 2193271, 10974036, 10.1084/jem.192.5.705.
43. Demedts IK, Bracke KR, Van Pottelberge GR, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175:998-1005. 10.1164/rccm.200608-1113OC, 17332482.
44. De Boer WI, van Schadewijk SA, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158:1951-1957. 9847291.
45. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998, 187:961-966. 2212193, 9500798, 10.1084/jem.187.6.961.
46. Coggle JE, Tarling JD. The proliferation kinetics of pulmonary alveolar macrophages. J Leukoc Biol 1984, 35:317-327.
47. Lai JP, Douglas SD, Ho WZ. Human lymphocytes express substance P and its receptor. J Neuroimmunol 1998, 86:80-86. 10.1016/S0165-5728(98)00025-3, 9655475.
48. Schratzberger P, Reinisch N, Prodinger WM, Kahler CM, Sitte BA, Bellmann R, Fischer-Colbrie R, Winkler H, Wiedermann CJ. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 1997, 158:3895-3901.
49. De Swert KO, Tournoy KG, Joos GF, Pauwels RA. The role of the tachykinin NK1 receptor in airway changes in a mouse model of allergic asthma. J Allergy Clin Immunol 2004, 113:1093-1099. 10.1016/j.jaci.2004.03.015, 15208590.
50. Xu J, Xu F, Wang R, Seagrave J, Lin Y, March TH. Cigarette smoke-induced hypercapnic emphysema in C3H mice is associated with increases of macrophage metalloelastase and substance P in the lungs. Exp Lung Res 2007, 33:197-215. 10.1080/01902140701459514, 17620183.
51. Xu J, Xu F, Barrett E. Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice. Am J Physiol Lung Cell Mol Physiol 2008, 295:L162-L170. 10.1152/ajplung.00282.2007, 18441096.
52. Tuder RM, Petrache I, Elias JA, Voelkel NF, Henson PM. Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol 2003, 28:551-554. 10.1165/rcmb.F269, 12707010.
53. Lucattelli M, Fineschi S, Geppetti P, Gerard NP, Lungarella G. Neurokinin-1 receptor blockade and murine lung tumorigenesis. Am J Respir Crit Care Med 2006, 174:674-683. 10.1164/rccm.200602-193OC, 16799078.
54. Soutiere SE, Tankersley CG, Mitzner W. Differences in alveolar size in inbred mouse strains. Respir Physiol Neurobiol 2004, 140:283-291. 10.1016/j.resp.2004.02.003, 15186789.
55. Joos GF, De Swert KO, Schelfhout V, Pauwels RA. The role of neural inflammation in asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci 2003, 992:218-230.
56. Canning BJ. Neurokinin3 receptor regulation of the airways. Vascul Pharmacol 2006, 45:227-234. 10.1016/j.vph.2005.08.031, 16945590.
57. Schelfhout V, Louis R, Lenz W, Heyrman R, Pauwels R, Joos G. The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma. Pulm Pharmacol Ther 2006, 19:413-418. 10.1016/j.pupt.2005.10.007, 16364669.